RxDoctor Payments Data

Thomas Feeny, PA

Physician Assistant · Dayton, OHNPI 1467478024

Payments from drug & device makers

$7,318in general payments, 2019–2025

Across 348 payments — averaging $21.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Johnson & Johnson$981
  • Takeda Pharmaceuticals U.S.A., Inc.$660
  • Sanofi$409
  • Lilly USA, LLC$369
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$7,14798%
  • Education$1712%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,318 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$26,761
Medicare patients
280
Services billed
346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban37$19,980
LinzessLinaclotide21$19,337
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates149$9,152
Pantoprazole Sodium209$6,013
ClenpiqSod Picosulf/Mag Ox/Citric Ac29$5,097
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C25$3,437
Sucralfate22$2,371
Ondansetron Hcl11$1,966
Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc20$1,930
Ondansetron OdtOndansetron39$1,136
Omeprazole99$991
Metoprolol Succinate48$800
Ranolazine ErRanolazine14$773
Atorvastatin Calcium79$705
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl34$698

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$48$19,98037 claims
AbbVieLinzess$1,754$19,33721 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu$1,275$3,43725 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →